Clinical features of infants with SARS-CoV-2 infection : a systematic review and meta-analysis

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to coronavirus disease 2019 (COVID-19) and is a public health problem. This meta-analysis reviewed the clinical features of SARS-CoV-2 infection among infants.

METHODS: PubMed, Scopus, Web of Science, and the Cochrane Library were searched for studies on clinical features of infants with SARS-CoV-2 published before May 1, 2022. Two authors screened and extracted data on the number of infants with SARS-CoV-2 infection, clinical features, and number of clinical features. The proportion of asymptomatic infection, mild symptoms, moderate symptoms, severe symptoms, and the clinical features were analyzed.

RESULTS: Forty-four studies with 6,304 infants with SARS-CoV-2 infections were included in this study. The proportion of asymptomatic infection was 20% (95% CI: 11-28%, I2=97%, P<0.01) in infants with SARS-CoV-2 infections. The proportion of infants with mild, moderate, and severe symptoms was 48% (95% CI: 30-65%, I2=96%, P<0.01), 27% (95% CI: 10-44%, I2=93%, P<0.01), and 8% (95% CI: 0-16%, I2=90%, P<0.01), respectively. Notably, the most common clinical features of infants with SARS-CoV-2 infection were fever (64%), cough (34%), and nasal symptoms (31%).

CONCLUSIONS: This meta-analysis found that 20% of infants with SARS-CoV-2 infections were asymptomatic, while most infants with COVID-19 presented with mild symptoms.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Annals of palliative medicine - 11(2022), 11 vom: 12. Nov., Seite 3394-3408

Sprache:

Englisch

Beteiligte Personen:

Xiao, Feifan [VerfasserIn]
Tang, Meiling [VerfasserIn]
Yan, Kai [VerfasserIn]
Zhou, Wenhao [VerfasserIn]

Links:

Volltext

Themen:

Clinical features
Coronavirus disease 2019 (COVID-19)
Infants
Journal Article
Meta
Meta-Analysis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Systematic Review

Anmerkungen:

Date Completed 06.12.2022

Date Revised 06.12.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.21037/apm-22-933

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM348804792